2020 - 2024 An international, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid unresponsive cancer-related neuropathic pain: Phase III trial
2017 - 2021 Development of evidence-based standard drug therapy for refractory neuropathic cancer pain
2019 - 2021 医療用麻薬の乱用リスク要因の分析と適正使用促進のための研究
2016 - 2020 A psychotherapy aiming at prognosis improvement in breast cancer patients: a preliminary study using autonomy and quality of life as indicators
2017 - 2020 がん患者の難治性神経障害性疼痛へのエビデンスに基づく標準的薬物療法の開発
2014 - 2018 Use of duloxetine after pregabalin administration to neuropathic pain in cancer patients
Junji Yamaguchi, Ryoichi Sadahiro, Takatoshi Hirayama, Saho Wada, Rika Nakahara, Hiromichi Matsuoka. Severe behavioral and psychological symptoms of dementia successfully treated at home with a blonanserin transdermal patch: A case report. Neuropsychopharmacology reports. 2024
Tatsuo Akechi, Toshiaki A Furukawa, Hisashi Noma, Hiroji Iwata, Tatsuya Toyama, Kenji Higaki, Hiromichi Matsuoka, Sadamoto Zenda, Tsuguo Iwatani, Kazuhisa Akahane, et al. Optimizing smartphone psychotherapy for depressive symptoms in patients with cancer: Multiphase optimization strategy using a decentralized multicenter randomized clinical trial (J-SUPPORT 2001 Study). Psychiatry and clinical neurosciences. 2024
Junji Yamaguchi, Takatoshi Hirayama, Ryoichi Sadahiro, Rika Nakahara, Hiromichi Matsuoka. Delirium due to Trousseau syndrome treated with memantine and perospirone: A case report. Psychiatry and Clinical Neurosciences Reports. 2023. 2. 4. e159
Yoshihiko Fujita, Hiromichi Matsuoka, Yasutaka Chiba, Junji Tsurutani, Takeshi Yoshida, Kiyohiro Sakai, Miki Nakura, Ryo Sakamoto, Chihiro Makimura, Yoichi Ohtake, et al. Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain. Oncology letters. 2023. 26. 2. 355-355
Ryoichi Sadahiro, Kotaro Hatta, Takuhiro Yamaguchi, Enokido Masanori, Yoshinobu Matsuda, Asao Ogawa, Yusei Iwata, Akihiro Tokoro, Rika Nakahara, Takatoshi Hirayama, et al. A multi-centre, double-blind, randomized, placebo-controlled trial to evaluate the effectiveness and safety of ramelteon for the prevention of postoperative delirium in elderly cancer patients: a study protocol for JORTC-PON2/J-SUPPORT2103/NCCH2103. Japanese journal of clinical oncology. 2023. 53. 9. 851-857
2017/08 - 2018/12 University of Technology Sydney(UTS) Faculty of Health, Palliative Care Clinical Studies Collaborative(PaCCSC) Visiting Professor
Committee career (4):
2016 - 現在 日本心療内科学会 評議員
2014 - 現在 日本緩和医療学会 代議員
2014 - 現在 日本サイコオンコロジー学会 理事
2011 - 現在 日本心身医学会 代議員
Awards (5):
2021/06 - 日本緩和医療学会 Best of JSPM 2021
2018/12 - 日本行動医学会 荒記記念賞
2018/10 - 平成30年日本サイコオンコロジー学会 奨励賞
2014/08 - The 16th Congress of Asian College of Psychosomatic Medicine Best Oral Award(2014)
2013 - 平成25年度日本サイコオンコロジー学会 教育功労賞
Association Membership(s) (7):
JAPANESE SOCIETY OF BEHAVIORAL MEDICINE
, 日本臨床腫瘍学会
, 日本緩和医療学会
, 日本サイコオンコロジー学会
, JAPANESE SOCIETY OF PSYCHOSOMATIC MEDICINE
, JAPANESE SOCIETY OF PSYCHOSOMATIC INTERNAL MEDICINE
, THE JAPANESE SOCIETY OF INTERNAL MEDICINE